6365 results for "11+1双色球多少钱一注"

in 21.43 milliseconds.

• Targeted capture ctDNA Library CRCQV40Run027-11

  Targeted capture ctDNA Library CRCQV40Run027-11 from patient PBC0004565, saliva sample

  Dataset EGAD00001010388

• Targeted capture ctDNA Library CRCQV42Run051-11

  Targeted capture ctDNA Library CRCQV42Run051-11 from patient PBC0002989, plasma sample

  Dataset EGAD00001010805

• Targeted capture ctDNA Library CRCQV42Run049-11

  Targeted capture ctDNA Library CRCQV42Run049-11 from patient PBC0001068, buffy coat sample

  Dataset EGAD00001010764

• Targeted capture ctDNA Library CRCQV34Run011-11

  Targeted capture ctDNA Library CRCQV34Run011-11 from patient PBC0002255, plasma baseline sample

  Dataset EGAD00001010365

• Targeted capture ctDNA Library CRCQV42Run033-11

  Targeted capture ctDNA Library CRCQV42Run033-11 from patient PBC0002294, buffy coat sample

  Dataset EGAD00001010550

• Targeted capture ctDNA Library CRCQV42Run047-11

  Targeted capture ctDNA Library CRCQV42Run047-11 from patient PBC0001310, buffy coat sample

  Dataset EGAD00001010723

• Targeted capture ctDNA Library CRCQV42Run048-11

  Targeted capture ctDNA Library CRCQV42Run048-11 from patient PBC0001515, buffy coat sample

  Dataset EGAD00001010743

• Targeted capture ctDNA Library CRCQV42Run050-11

  Targeted capture ctDNA Library CRCQV42Run050-11 from patient PBC0001284, buffy coat sample

  Dataset EGAD00001010784

• Targeted capture ctDNA Library CRCQV34Run002-11

  Targeted capture ctDNA Library CRCQV34Run002-11 from patient PBC0002429, plasma baseline sample

  Dataset EGAD00001010328

• Targeted capture ctDNA Library CRCQV42Run016-11

  Targeted capture ctDNA Library CRCQV42Run016-11 from patient PBC0001467, plasma baseline sample

  Dataset EGAD00001010399

• Targeted capture ctDNA Library CRCQV42Run017-11

  Targeted capture ctDNA Library CRCQV42Run017-11 from patient PBC0001845, plasma 6 month sample

  Dataset EGAD00001010404

• Targeted capture ctDNA Library CRCQV42Run046-11

  Targeted capture ctDNA Library CRCQV42Run046-11 from patient PBC0001284, plasma 6 month sample

  Dataset EGAD00001010702

• Targeted capture ctDNA Library CRCQV42Run028-11

  Targeted capture ctDNA Library CRCQV42Run028-11 from patient PBC0003643, plasma baseline sample

  Dataset EGAD00001010501

• Targeted capture ctDNA Library CRCQV42Run036-11

  Targeted capture ctDNA Library CRCQV42Run036-11 from patient PBC0002826, plasma 15 month sample

  Dataset EGAD00001010593

• Targeted capture ctDNA Library CRCQV42Run045-11

  Targeted capture ctDNA Library CRCQV42Run045-11 from patient PBC0004156, plasma 6 month sample

  Dataset EGAD00001010682

• Targeted capture ctDNA Library CRCQV42Run035-11

  Targeted capture ctDNA Library CRCQV42Run035-11 from patient PBC0001589, plasma 30 month sample

  Dataset EGAD00001010578

• Targeted capture ctDNA Library CRCQV42Run039-11

  Targeted capture ctDNA Library CRCQV42Run039-11 from patient PBC0001323, plasma 6 month sample

  Dataset EGAD00001010607

• Targeted capture ctDNA Library CRCQV42Run043-11

  Targeted capture ctDNA Library CRCQV42Run043-11 from patient PBC0001310, plasma 6 month sample

  Dataset EGAD00001010641

• Targeted capture ctDNA Library CRCQV42Run044-11

  Targeted capture ctDNA Library CRCQV42Run044-11 from patient PBC0001515, plasma 3 month sample

  Dataset EGAD00001010661

• Targeted capture ctDNA Library CRCQV42Run025-11

  Targeted capture ctDNA Library CRCQV42Run025-11 from patient PBC0003595, TNBC FFPE sample

  Dataset EGAD00001010477

• Targeted capture ctDNA Library CRCQV42Run021-11

  Targeted capture ctDNA Library CRCQV42Run021-11 from patient PBC0001516, TNBC FFPE sample

  Dataset EGAD00001010434

• Targeted capture ctDNA Library CRCQV34Run005-11

  Targeted capture ctDNA Library CRCQV34Run005-11 from patient PBC0002595, TNBC FFPE sample

  Dataset EGAD00001010342

• McGill EMC Release 4 in tissue "Brodmann (1909) area 11"

  McGill EMC Release 4 in tissue "Brodmann (1909) area 11"

  Dataset EGAD00001001284

• Targeted capture ctDNA Library CRCQV42Run029-11

  Targeted capture ctDNA Library CRCQV42Run029-11 from patient PBC0001353, TNBC FFPE sample

  Dataset EGAD00001010511

• Targeted capture ctDNA Library CRCQV42Run024-11

  Targeted capture ctDNA Library CRCQV42Run024-11 from patient PBC0001306, TNBC FFPE sample

  Dataset EGAD00001010465

• Amplicon sequencing of IPC-298 and MelJuso parental cell lines and Belvarafenib resistant IPC-298 colony

  Amplicon seqeuencing of (1) wildtype IPC298 cell line grown for 3-4 weeks with DMSO, amplified for ARAF exon 11 (2) IPC298 cells treated for 3-4 weeks with 10uM belvarafenib, isolated colony 9, amplified for ARAF exon 11 (3) MelJuso cell line grown with DMSO, amplified for ARAF exon 11

  Dataset EGAD00001007061

• Whole genome sequencing data of high-grade serous ovarian cancer samples (set 9 part 1)

  Whole genome sequencing data of 6 high-grade serous carcinoma (HGSC) patients (11 samples) sequenced with MGISEQ-2000

  Dataset EGAD00001011353

• SIGi001-A-11 / SAMEA4451118 WGS data

  The iPSC line SIGi001-A-11 / SAMEA4451118 has undergone whole genome sequencing. Whole genome sequencing was done using Illumina HiSeq X Five platform with a reference genome of GRCh38. Raw data as FASTQ files and analysed data as CRAM files are available for this sample, in this dataset. The iPSC line SIGi001-A-11 is available for research use at www.EBiSC.org.

  Dataset EGAD50000001075

• Single-cell RNA sequencing data of human lymph node samples generated with BD Rhapsody

  The single cell data were generated based on four cartridges. The samples are multiplexed: 0. Sample Run Id Hash Gender Age 1. FL-6 Run1_C1 4 f 71 2. rLN-3 Run1_C1 6 f 72 3. DLBCL-4 Run1_C1 7 f 68 4. DLBCL-1 Run1_C1 8 m 66 5. FL-4 Run1_C1 9 m 41 6. DLBCL-3 Run1_C2 10 f 60 7. rLN-4 Run1_C2 11 f 58 8. rLN-5 Run1_C2 12 m 61 9. FL-1 Run2_C1 1 f 81 10. DLBCL-2 Run2_C1 2 m 80 11. rLN-2 Run2_C1 3 f 42 12. FL-5 Run2_C1 4 m 66 13. DLBCL-8 Run2_C1 5 m 64 14. DLBCL-6 Run2_C2 6 m 76 15. rLN-1 Run2_C2 7 m 39 16. FL-3 Run2_C2 8 f 76 17. DLBCL-5 Run2_C2 9 m 66 18. FL-2 Run2_C2 10 f 58 19. DLBCL-7 Run2_C2 11 f 71

  Dataset EGAD00001010044

• Synthetic - GDI synthetic dataset (Population 11 Finland, Subgroup 2)

  Synthetic - This dataset contains the pheno-clinical and genomic information of 42046 individuals from COVID Population 11 Finland, Subgroup 2. 2010 are affected by Phenotype 1, 2010 are affected by Phenotype 2, 188 are affected by Phenotype 1 and 2, and 37838 are control. The dataset also contains the information about the smoking habits of each individual.

  Dataset EGAD50000000955

• Genomic and transcriptomic determinants of host susceptibility, protection, and viral mutation in experimental SARS CoV-2 infection: RNA (2025-08-11)

  Single-cell profiling of healthy adult volunteers that were inoculated with SARS-CoV-2. . This dataset contains all the data available for this study on 2025-08-11.

  Dataset EGAD00001015679

• Recurrent adeno-associated virus 2-related insertional mutagenesis in human hepatocellular carcinomas

  Hepatocellular carcinomas (HCC) are liver tumors related to various etiologies including alcohol intake, hepatitis B (HBV) or C (HCV) virus infection. Additional risk factors remain to be identified, particularly in patients who develop HCC without cirrhosis. We identified clonal integration of adeno-associated virus type 2 (AAV2) in 11 out of 193 HCC. These AAV2 integrations occurred within known cancer driver genes, namely, CCNA2 (Cyclin A2, 4 cases), TERT (Telomerase Reverse-Transcriptase, 1 case), CCNE1 (Cyclin E1, 3 cases), TNFSF10 (Tumor Necrosis Factor member 10, 2 cases) or KMT2B (Lysine (K)-Specific Methyltransferase 2B, 1 case) leading to over-expression of the target genes. Tumors with viral integration mainly developed in non-cirrhotic liver (9 out of 11 cases) and without known risk factors (6 out of 11) suggesting a pathogenic role of AAV2 in these patients. In conclusion, AAV2 is a DNA virus associated with oncogenic insertional mutagenesis in human HCC.

  Study EGAS00001001284

• subset of 11 samples RRMM (RNA-Seq and WGS) from study EGAS00001005973 used also in study EGAS00001006538

  subset of 11 samples (RNA-Seq and WGS) from study EGAS00001005973, which was published earlier and are linked here to study EGAS00001006538

  Dataset EGAD00001009679

• Single-cell analysis of the multicellular ecosystem in viral carcinogenesis by HTLV-1

  Single-cell RNA sequencing (scRNA-seq), antibody-derived tag sequencing (scADT-seq) and T/B-cell receptor (TCR/BCR) sequencing (scTCR/BCR-seq) on peripheral blood mononuclear cells (PBMCs) obtained from 30 ATL patients (34 samples including 4 sequential ones), 11 HTLV-1-infected asymptomatic carriers, and 4 healthy donors.

  Study EGAS00001004936

• DDD DATAFREEZE 2014-11-04: 4293 trios - VCF files

  DDD DATAFREEZE 2014-11-04: 4293 trios - VCF files

  Dataset EGAD00001001848

• DDD DATAFREEZE 2014-11-04: 4293 trios - phenotypic and family descriptions

  DDD DATAFREEZE 2014-11-04: 4293 trios - phenotypic and family descriptions

  Dataset EGAD00001001977

• DDD DATAFREEZE 2014-11-04: 4293 trios - exome sequence CRAM files

  DDD DATAFREEZE 2014-11-04: 4293 trios - exome sequence CRAM files

  Dataset EGAD00001002748

• Single-cell T-cell receptor sequencing data of peripheral blood mononuclear cells obtained from 30 ATL patients, 11 HTLV-1-infected asymptomatic carriers, and 4 healthy donors.

  Single-cell T-cell receptor sequencing (scTCR-seq) data of peripheral blood mononuclear cells (PBMCs) obtained from 30 ATL patients (34 samples including 4 sequential ones), 11 HTLV-1-infected asymptomatic carriers, and 4 healthy donors.

  Dataset EGAD00001007014

• WHOLE GENOME SEQUENCING FOR THE CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA IN VHL PATIENT

  To characterize clear cell Renal Cell Carcinoma (ccRCC), we set up a comprehensive multi-omics pilot study on a VHL-ccRCC-patient. Whole Genome Sequencing (WGS) was applied on six ccRCCs, four cysts and one blood DNA sample as germinal control. Raw-data were analyzed with GENomics-DRAGEN platform. We will upload WGS-Data for 11 samples (6 ccRCCs, 4 Cysts, 1 blood).

  Dataset EGAD50000000425

• Circulating RNAs prior to endometrial cancer diagnosis

  We analyzed circulating RNA levels using small RNA sequencing, targeting RNA in the size range 17 to 47 nucleotides, in samples collected prior to endometrial cancer diagnosis compared to cancer-free controls. The analysis included 316 cases with samples collected 1-11 years prior to diagnosis , and 316 matched controls, both from the Janus Serum Bank Cohort in Norway.

  Study EGAS50000000267

• Single-cell B-cell receptor sequencing data of peripheral blood mononuclear cells obtained from 30 ATL patients, 11 HTLV-1-infected asymptomatic carriers, and 4 healthy donors.

  Single-cell B-cell receptor sequencing (scBCR-seq) data of peripheral blood mononuclear cells (PBMCs) obtained from 30 ATL patients (34 samples including 4 sequential ones), 11 HTLV-1-infected asymptomatic carriers, and 4 healthy donors.

  Dataset EGAD00001007013

• BLUEPRINT release August 2015, RNA-Seq for Multiple myeloma, on genome GRCh38

  RNA-Seq data for 11 Multiple myeloma sample(s). 11 run(s), 11 experiment(s), 11 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820

  Dataset EGAD00001001471

• Transcriptomic changes in placenta associated with anesthesia, delivery mode and maternal diabetes

  Samples were from 34 mothers, 6 with gestational diabetes, 14 with type 1 diabetes and 14 without diabetes history with either vaginal (N=17) or cesarean section (n=17) delivery, comprising primary planned section (N=9) or secondary emergency section (N=8). Anesthesia methods during delivery included spinal (N=11), epidural (N=11), or local anesthesia (N=6), with unknown anesthesia information for six cases. Samples from each other were from the Villous and the Decidua part of the Placenta

  Dataset EGAD50000000701

• BLUEPRINT release August 2014, Bisulfite-Seq for Plasma cell

  Bisulfite-Seq data for 1 Plasma cell sample(s). 11 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811

  Dataset EGAD00001000927

• BLUEPRINT release January 2015, Bisulfite-Seq for plasma cell

  Bisulfite-Seq data for 1 plasma cell sample(s). 11 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811

  Dataset EGAD00001001160

• Single-cell RNA-seq of peripheral blood mononuclear cells in classic Hodgkin lymphoma

  Classic Hodgkin lymphoma (cHL) is a largely MHC class I-negative tumor with recurrent 9p24.1/ PD-L1/ PD-L2 copy gains and the highest reported response rates to PD-1 blockade. We utilized scRNA sequencing to characterize the peripheral immune response to PD-1 blockade and more broadly define non-CD8+ dependent mechanisms of immune evasion in cHL. Peripheral blood mononuclear cells were obtained from 20 patients with relapsed/refractory (R/R) cHL treated with PD-1 blockade (nivolumab) on the CheckMate 205 clinical trial (paired samples from cycle 1 day 1 [C1D1] and cycle 4 day 1 [C4D1]), 11 patients with newly diagnosed, previously untreated cHL and 13 healthy donors.

  Study EGAS00001007569

• The spatio-temporal evolution of lymph node spread in early breast cancer

  Purpose: The most significant prognostic factor in early breast cancer is lymph node involvement. This stage between localised and systemic disease is key to understanding breast cancer progression, however our knowledge of the evolution of lymph node malignant invasion remains limited, as most currently available data derive from primary tumours. Experimental design: In 11 treatment-naïve node positive early breast cancer patients without clinical evidence of distant metastasis, we investigated lymph node evolution using spatial multi-region sequencing (n=78 samples) of primary and lymph node deposits and genomic profiling of matched longitudinal circulating tumour DNA (ctDNA). Results: Linear evolution from primary to lymph node was rare (1/11) whereas the majority of cases displayed either early divergence between primary and nodes (4/11), or no detectable divergence (6/11) where both primary and nodal cells belonged to a single recent expansion of a metastatic clone. Divergence of metastatic subclones was driven in part by APOBEC. Longitudinal ctDNA samples from 2 subjects taken peri-operatively reflected the two major evolutionary patterns and demonstrate that private mutations can be detected even from early metastatic nodal deposits. Moreover, node removal resulted in disappearance of private lymph node mutations in ctDNA.Conclusions: This study sheds new light on a crucial evolutionary step in the natural history of breast cancer, demonstrating early establishment of axillary lymph node metastasis in a substantial proportion of patients.

  Study EGAS00001002947

• Pre-diagnostic saliva microbiota of Finnish children with autoimmune diseases

  Pre-diagnostic saliva microbiota samples of Finnish children (aged 11/12 years). This is a case-control study, where case refers to the children who developed Type 1 DM or IBD later in life and control refers to the children who were free from these diseases. The aim of the study was to find biomarkers in saliva microbiota that may help us predict DM or IBD before the onset of these diseases.

  Study EGAS00001006949

• Single-cell antibody-derived tag sequencing data of peripheral blood mononuclear cells obtained from 30 ATL patients, 11 HTLV-1-infected asymptomatic carriers, and 4 healthy donors.

  Single-cell antibody-derived tag sequencing (scADT-seq) data of peripheral blood mononuclear cells (PBMCs) obtained from 30 ATL patients (34 samples including 4 sequential ones), 11 HTLV-1-infected asymptomatic carriers, and 4 healthy donors.

  Dataset EGAD00001007017

• BLUEPRINT release January 2015, Bisulfite-Seq for effector memory CD8-positive, alpha-beta T cell

  Bisulfite-Seq data for 1 effector memory CD8-positive, alpha-beta T cell sample(s). 11 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811

  Dataset EGAD00001001200